Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...

Don M. Benson, MD, PhD, has cared for patients at James Cancer Hospital in Ohio for 22 years, where he and his team see approximately 10,000 patient visits each year.

GSK has announced positive headline interim analysis outcomes from a Phase III trial, which is evaluating Blenrep (belantamab ...

Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...

Multiple myeloma is a type of cancer where plasma cells in bone marrow replicate out of control. Doctors use the acronym CRAB to diagnose myeloma by identifying four symptoms. The National Cancer ...

Once your computers have the program installed and running, you’ll need to get them talking to each other. On the server machine, click the Configure Server button. In the upper left-hand corner ...

Doctors do not usually recommend surgery for multiple myeloma. However, it may be necessary to repair damaged bones, replace bone marrow, or treat spinal cord compression. Surgery to treat ...

The combination of MGTA-145 and plerixafor demonstrated effective hematopoietic stem cell (HSC) mobilization in patients with multiple myeloma ... stimulating factor (G-CSF) or G-CSF with or ...

Historically, we evaluated myeloma through monoclonal proteins or free light chains in the blood and urine and percentage of plasma cells in the bone marrow. But this is like the iceberg ...

Credit: Michael Vi/Shutterstock The European label for Johnson and Johnson Innovation Medicine’s (J&J) Darzalex (daratumumab) has been expanded to include patients with newly diagnosed multiple ...

Revlimid (lenalidomide) is a brand-name oral capsule prescribed to treat multiple myeloma and certain other blood cell cancers in adults. This article covers topics such as side effects ...

Multiple Sclerosis Centre of Catalonia (Cemcat), Department ... The application of AI-based methodologies to serum/blood and CSF biomarkers has been less explored, according to the literature, despite ...